Pediatric oncologist Paul Meyers gives us a snapshot of where treatment for childhood cancers has been – and the promising directions it’s taking in the future.
Common genetic alterations in neuroblastoma tumors may help doctors predict the likelihood the cancer will spread to the brain.
On the occasion of Childhood Cancer Awareness Month, pediatric oncologist Paul A. Meyers talks about the evolution of pediatric cancer research and treatment at Memorial Sloan Kettering.
In a large-scale genome-sequencing study, researchers have discovered mutations in neuroblastoma tumors that could aid the development of diagnostic tests and therapies.
Fred’s Team runner Danielle Kelly ran the ING New York City Marathon for her daughter, Maggie, who was treated for neuroblastoma at Memorial Sloan Kettering.